{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:46:59Z","timestamp":1769064419031,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00392-023-02322-0","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T13:02:11Z","timestamp":1698757331000},"page":"875-883","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Sacubitril\/valsartan and the risk of incident dementia in heart failure: a nationwide propensity-matched cohort study"],"prefix":"10.1007","volume":"113","author":[{"given":"Hyun-Jung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7950-2131","authenticated-orcid":false,"given":"Hyung-Kwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bong-Seong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Do","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soongu","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan Soon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Min","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Bean","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heesun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"issue":"11","key":"2322_CR1","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR et al (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371(11):993\u20131004","journal-title":"N Engl J Med"},{"issue":"18","key":"2322_CR2","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM et al (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145(18):e895\u2013e1032","journal-title":"Circulation"},{"issue":"36","key":"2322_CR3","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M et al (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599\u20133726","journal-title":"Eur Heart J"},{"key":"2322_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fnagi.2013.00098","volume":"5","author":"MO Grimm","year":"2013","unstructured":"Grimm MO, Mett J, Stahlmann CP, Haupenthal VJ, Zimmer VC, Hartmann T (2013) Neprilysin and A\u03b2 clearance: impact of the APP intracellular domain in NEP regulation and implications in Alzheimer\u2019s disease. Front Aging Neurosci 5:98","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"2322_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s40256-020-00445-7","volume":"21","author":"J Galo","year":"2021","unstructured":"Galo J, Celli D, Colombo R (2021) Effect of sacubitril\/valsartan on neurocognitive function: current status and future directions. Am J Cardiovasc Drugs 21(3):267\u2013270","journal-title":"Am J Cardiovasc Drugs"},{"issue":"10","key":"2322_CR6","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jchf.2020.06.020","volume":"8","author":"KF Docherty","year":"2020","unstructured":"Docherty KF, Vaduganathan M, Solomon SD, McMurray JJV (2020) Sacubitril\/valsartan: neprilysin inhibition 5 years after PARADIGM-HF. JACC Heart Fail 8(10):800\u2013810","journal-title":"JACC Heart Fail"},{"key":"2322_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104833","volume":"139","author":"PK Singh","year":"2020","unstructured":"Singh PK, Chen ZL, Ghosh D, Strickland S, Norris EH (2020) Increased plasma bradykinin level is associated with cognitive impairment in Alzheimer\u2019s patients. Neurobiol Dis 139:104833","journal-title":"Neurobiol Dis"},{"issue":"5","key":"2322_CR8","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/bcp.12861","volume":"81","author":"TH Langenickel","year":"2016","unstructured":"Langenickel TH, Tsubouchi C, Ayalasomayajula S, Pal P, Valentin MA, Hinder M et al (2016) The effect of LCZ696 (sacubitril\/valsartan) on amyloid-beta concentrations in cerebrospinal fluid in healthy subjects. Br J Clin Pharmacol 81(5):878\u2013890","journal-title":"Br J Clin Pharmacol"},{"key":"2322_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.taap.2017.03.014","volume":"323","author":"HA Schoenfeld","year":"2017","unstructured":"Schoenfeld HA, West T, Verghese PB, Holubasch M, Shenoy N, Kagan D et al (2017) The effect of angiotensin receptor neprilysin inhibitor, sacubitril\/valsartan, on central nervous system amyloid-beta concentrations and clearance in the cynomolgus monkey. Toxicol Appl Pharmacol 323:53\u201365","journal-title":"Toxicol Appl Pharmacol"},{"key":"2322_CR10","doi-asserted-by":"publisher","first-page":"394632023116146","DOI":"10.1177\/03946320231161469","volume":"37","author":"AS El-Din Hussein","year":"2023","unstructured":"El-Din Hussein AS, Abou-El Nour RKE, Khorshid OA, Osman AS (2023) Study of the possible effect of sacubitril\/valsartan combination versus valsartan on the cognitive function in Alzheimer\u2019s disease model in rats. Int J Immunopathol Pharmacol 37:3946320231161469","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"2","key":"2322_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/fcp.12837","volume":"37","author":"SH Hammadi","year":"2023","unstructured":"Hammadi SH, Hassan MA, Allam EA, Elsharkawy AM, Shams SS (2023) Effect of sacubitril\/valsartan on cognitive impairment in colchicine-induced Alzheimer\u2019s model in rats. Fundam Clin Pharmacol 37(2):275\u2013286","journal-title":"Fundam Clin Pharmacol"},{"issue":"1","key":"2322_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ejhf.687","volume":"19","author":"JA Cannon","year":"2017","unstructured":"Cannon JA, Shen L, Jhund PS, Kristensen SL, Kober L, Chen F et al (2017) Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction. Eur J Heart Fail 19(1):129\u2013137","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"2322_CR13","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1111\/cns.14195","volume":"29","author":"C Chen","year":"2023","unstructured":"Chen C, Ding L, Fu F, Xiao J (2023) Updated insights on dementia-related risk of sacubitril\/valsartan: a real-world pharmacovigilance analysis. CNS Neurosci Ther 29(9):2548\u20132554","journal-title":"CNS Neurosci Ther"},{"issue":"8","key":"2322_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.cardfail.2018.04.010","volume":"24","author":"A Perlman","year":"2018","unstructured":"Perlman A, Hirsh Raccah B, Matok I, Muszkat M (2018) Cognition- and dementia-related adverse effects with sacubitril-valsartan: analysis of the FDA adverse event report system database. J Card Fail 24(8):533\u2013536","journal-title":"J Card Fail"},{"key":"2322_CR15","unstructured":"Bavry AA (2022) Efficacy and safety of sacubitril\/valsartan compared to valsartan on cognitive function in patients with chronic heart failure and preserved ejection fraction\u2014perspective. American College of Cardiology Foundation. https:\/\/www.acc.org\/Latest-in-Cardiology\/Clinical-Trials\/2022\/08\/25\/03\/38\/PERSPECTIVE#references-for-article. Accessed 17 July 2023"},{"issue":"9","key":"2322_CR16","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4070\/kcj.2020.0171","volume":"50","author":"EK Choi","year":"2020","unstructured":"Choi EK (2020) Cardiovascular research using the Korean national health information database. Korean Circ J 50(9):754\u2013772","journal-title":"Korean Circ J"},{"issue":"1","key":"2322_CR17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1161\/HYPERTENSIONAHA.121.17283","volume":"79","author":"CJ Lee","year":"2022","unstructured":"Lee CJ, Lee JY, Han K, Kim DH, Cho H, Kim KJ et al (2022) Blood pressure levels and risks of dementia: a nationwide study of 4.5 million people. Hypertension 79(1):218\u2013229","journal-title":"Hypertension"},{"issue":"25","key":"2322_CR18","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC (2009) Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28(25):3083\u20133107","journal-title":"Stat Med"},{"issue":"4","key":"2322_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1177\/0091270009343932","volume":"50","author":"J Gu","year":"2010","unstructured":"Gu J, Noe A, Chandra P, Al-Fayoumi S, Ligueros-Saylan M, Sarangapani R et al (2010) Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi). J Clin Pharmacol 50(4):401\u2013414","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"2322_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2023.100372","volume":"2","author":"PKA Grewal","year":"2023","unstructured":"Grewal PKA, Myserlis EP, Goldschmidt ME, Butler J, Skopicki HA, Kalogeropoulos AP (2023) Sacubitril\/valsartan and cognitive outcomes in heart failure with reduced ejection fraction. JACC Adv 2(4):100372","journal-title":"JACC Adv"},{"issue":"5","key":"2322_CR21","doi-asserted-by":"publisher","first-page":"e519","DOI":"10.1212\/WNL.0000000000010022","volume":"95","author":"FJ Wolters","year":"2020","unstructured":"Wolters FJ, Chibnik LB, Waziry R, Anderson R, Berr C, Beiser A et al (2020) Twenty-seven-year time trends in dementia incidence in Europe and the United States: the Alzheimer Cohorts Consortium. Neurology 95(5):e519\u2013e531","journal-title":"Neurology"},{"issue":"3","key":"2322_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3390\/jcm11030819","volume":"11","author":"HS Kwon","year":"2022","unstructured":"Kwon HS, Jeong YW, Kim SH, Park KH, Seo SW, Na HR et al (2022) Annual incidence of dementia from 2003 to 2018 in metropolitan Seoul, Korea: a population-based study. J Clin Med 11(3):819","journal-title":"J Clin Med"},{"issue":"8","key":"2322_CR23","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.cardfail.2021.12.014","volume":"28","author":"S Vishwanath","year":"2022","unstructured":"Vishwanath S, Qaderi V, Steves CJ, Reid CM, Hopper I, Ryan J (2022) Cognitive decline and risk of dementia in individuals with heart failure: a systematic review and meta-analysis. J Card Fail 28(8):1337\u20131348","journal-title":"J Card Fail"},{"issue":"1","key":"2322_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5853\/jos.2017.02810","volume":"20","author":"W Kim","year":"2018","unstructured":"Kim W, Kim EJ (2018) Heart failure as a risk factor for stroke. J Stroke 20(1):33\u201345","journal-title":"J Stroke"},{"issue":"42","key":"2322_CR25","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.1093\/eurheartj\/ehac487","volume":"43","author":"T Kondo","year":"2022","unstructured":"Kondo T, Abdul-Rahim AH, Talebi A, Abraham WT, Desai AS, Dickstein K et al (2022) Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation. Eur Heart J 43(42):4469\u20134479","journal-title":"Eur Heart J"},{"issue":"14","key":"2322_CR26","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.jacc.2022.01.045","volume":"79","author":"C Li","year":"2022","unstructured":"Li C, Zhu Y, Ma Y, Hua R, Zhong B, Xie W (2022) Association of cumulative blood pressure with cognitive decline, dementia, and mortality. J Am Coll Cardiol 79(14):1321\u20131335","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"2322_CR27","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.34553","volume":"4","author":"C Dallaire-Theroux","year":"2021","unstructured":"Dallaire-Theroux C, Quesnel-Olivo MH, Brochu K, Bergeron F, O\u2019Connor S, Turgeon AF et al (2021) Evaluation of intensive vs standard blood pressure reduction and association with cognitive decline and dementia: a systematic review and meta-analysis. JAMA Netw Open 4(11):e2134553","journal-title":"JAMA Netw Open"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02322-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-023-02322-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02322-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T07:04:59Z","timestamp":1716275099000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-023-02322-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2322"],"URL":"https:\/\/doi.org\/10.1007\/s00392-023-02322-0","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]},"assertion":[{"value":"16 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HKK reports research grants from Inno.N, Janssen Korea, Chong Kun Dang, Boryung, Handok, GSK, Daewoong, Hanmi, Ildong, JW Pharmaceutical, Samjin, and Novartis. The remaining authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}